Suppr超能文献

慢性阻塞性肺疾病门诊患者气管切开术后下呼吸道感染及铜绿假单胞菌持续定植情况

Lower respiratory tract infections in chronic obstructive pulmonary disease outpatients with tracheostomy and persistent colonization by P. aeruginosa.

作者信息

Lusuardi M, Capelli A, Di Stefano A, Zaccaria S, Balbi B, Donner C F

机构信息

Division of Pulmonary Disease, IRCCS (Institute for Care and Research), Scientific Institute of Rehabilitation, Salvatore Maugeri Foundation, Veruno (NO) I-28010, Italy.

出版信息

Respir Med. 2003 Nov;97(11):1205-10. doi: 10.1016/s0954-6111(03)00231-2.

Abstract

Outpatients with tracheostomy can be managed with a low risk for severe airways infections despite colonization with pathogenic bacteria. No studies have been focused on chronic obstructive pulmonary disease (COPD), a condition known for recurrent exacerbations. The aim of our study was to verify whether at follow-up in tracheostomized COPD versus other disease outpatients, persistent P. aeruginosa colonization may influence the rate and treatment of lower respiratory tract infections (LRTI) or hospital admissions. Thirty-nine outpatients were considered: 24 were affected by COPD (age 66, 54-78 years, mean, range), 15 by restrictive lung disease (RLD) (57, 41-72 years). During an 18-month follow-up the number of LRTIs were recorded. Bacterial identifications were assessed at baseline and every month for 6 months in bronchial aspirates. The number of LRTI per patient was not significantly different between COPD [37, 1(0-6)] and RLD [18, 1(0-5)], [total, median (range)]. Persistent P. aeruginosa colonized 18 COPD (75%), 12 RLD patients (86%) and was not associated with an increased number of LRTI: 1(0-6) and 1(0-2), respectively. There were no differences in the number of hospital admissions: COPD 0(0-2), RLD 1(0-1), with a significant decrease versus before tracheostomy (P < 0.001). In conclusion, the rate of LRTI and hospital admissions in COPD outpatients with chronic tracheostomy was low, similar to non-COPD patients and independent of P. aeruginosa colonization.

摘要

尽管气管造口术门诊患者存在病原菌定植,但仍可在低严重气道感染风险下进行管理。目前尚无针对慢性阻塞性肺疾病(COPD)的研究,COPD是以反复发作为特征的疾病。我们研究的目的是验证在气管造口的COPD门诊患者与其他疾病门诊患者的随访中,铜绿假单胞菌持续定植是否会影响下呼吸道感染(LRTI)的发生率和治疗或住院情况。研究纳入了39例门诊患者:24例患有COPD(年龄66岁,范围54 - 78岁,均值),15例患有限制性肺疾病(RLD)(57岁,范围41 - 72岁)。在18个月的随访期间记录LRTI的发生次数。在基线时以及随后6个月每月对支气管吸出物进行细菌鉴定评估。COPD组[37次,中位数1(范围0 - 6)]和RLD组[18次,中位数1(范围0 - 5)] [总计,中位数(范围)]每位患者的LRTI次数无显著差异。持续定植铜绿假单胞菌的患者中,COPD有18例(75%),RLD有12例(86%),且与LRTI次数增加无关:分别为1(0 - 6)和1(0 - 2)。住院次数无差异:COPD为0(0 - 2),RLD为1(0 - 1),与气管造口术前相比显著减少(P < 0.001)。总之,慢性气管造口的COPD门诊患者的LRTI发生率和住院率较低,与非COPD患者相似,且与铜绿假单胞菌定植无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验